EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Comparison of clinical outcome between surgical treatment and particle beam therapy for pelvic bone sarcomas: A retrospective multicenter study in Japan

Toshiyuki Takemori, Hitomi Hara, Teruya Kawamoto, Naomasa Fukase, Ryoko Sawada, Shuichi Fujiwara, Ikuo Fujita, Takuya Fujimoto, Masayuki Morishita, Shunsuke Yahiro, Tomohiro Miyamoto, Masanori Saito und 22 weitere

Journal of Orthopaedic Science · 2025

DOI: 10.1016/j.jos.2024.06.007 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Orthopaedic Science, 2025. Verfasst von Toshiyuki Takemori und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan; Department of Orthopaedic Surgery, Hyogo Cance…. Hauptthemen laut MEDLINE: Bone Neoplasms, Pelvic Bones, Osteosarcoma, Proton Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Few studies have compared the clinical outcomes of patients with pelvic bone sarcomas treated surgically and those treated with particle beam therapy. This is a multicenter retrospective cohort study which compared the clinical outcomes of patients with pelvic bone sarcoma who underwent surgical treatment and particle beam therapy in Japan. METHODS: A total of 116 patients with pelvic bone sarcoma treated at 19 specialized sarcoma centers in Japan were included in this study. Fifty-seven patients underwent surgery (surgery group), and 59 patients underwent particle beam therapy (particle beam group; carbon-ion radiotherapy: 55 patients, proton: four patients). RESULTS: The median age at primary tumor diagnosis was 52 years in the surgery group and 66 years in the particle beam group (P < 0.001), and the median tumor size was 9 cm in the surgery group and 8 cm in the particle beam group (P = 0.091). Overall survival (OS), local control (LC), and metastasis-free survival (MFS) rates were evaluated using the Kaplan-Meier method and compared among 116 patients with bone sarcoma (surgery group, 57 patients; particle beam group, 59 patients). After propensity score matching, the 3-year OS, LC, and MFS rates were 82.9% (95% confidence interval [CI], 60.5-93.2%), 66.0% (95% CI, 43.3-81.3%), and 78.4% (95% CI, 55.5-90.5%), respectively, in the surgery group and 64.9% (95% CI, 41.7-80.8%), 86.4% (95% CI, 63.3-95.4%), and 62.6% (95% CI, 38.5-79.4%), respectively, in the particle beam group. In chordoma patients, only surgery was significantly correlated with worse LC in the univariate analysis. CONCLUSIONS: The groups had no significant differences in the OS, LC, and MFS rates. Among the patients with chordomas, the 3-year LC rate in the particle beam group was significantly higher than in the surgery group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsPelvic BonesOsteosarcomaProton TherapySarcomaHeavy Ion RadiotherapyHumansRetrospective StudiesFemaleMaleMiddle AgedAgedJapanAdultTreatment OutcomeYoung AdultSurvival Rate

Stichwörter der Autor:innen

Clinical outcomeParticle beam therapyPelvic bone sarcomaSurgery

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan; Department of Orthopaedic Surgery, Hyogo Cancer Center, Akashi 673-8558, Japan.
  • Department of Orthopaedic Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan. Electronic address: mitohi@med.kobe-u.ac.jp.
  • Department of Orthopaedic Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan; Division of Orthopaedic Surgery, Kobe University Hospital, International Clinical Cancer Research Center, Kobe 650-0…
  • Department of Orthopaedic Surgery, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
  • Department of Orthopaedic Surgery, Hyogo Cancer Center, Akashi 673-8558, Japan.
  • Department of Orthopaedic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

Zitieren

APA

Takemori, T., Hara, H., Kawamoto, T., Fukase, N., Sawada, R., Fujiwara, S., Fujita, I., Fujimoto, T., Morishita, M., Yahiro, S., Miyamoto, T., Saito, M., Sugaya, J., Hayashi, K., Kawashima, H., Torigoe, T., Nakamura, T., Kondo, H., Wakamatsu, T., …, & Akisue, T. (2025). Comparison of clinical outcome between surgical treatment and particle beam therapy for pelvic bone sarcomas: A retrospective multicenter study in Japan. Journal of Orthopaedic Science. https://doi.org/10.1016/j.jos.2024.06.007

Vancouver

Takemori T, Hara H, Kawamoto T, Fukase N, Sawada R, Fujiwara S, et al. Comparison of clinical outcome between surgical treatment and particle beam therapy for pelvic bone sarcomas: A retrospective multicenter study in Japan. Journal of Orthopaedic Science. 2025. doi:10.1016/j.jos.2024.06.007

BibTeX
@article{Takemori2025,
  author = {Takemori, Toshiyuki and Hara, Hitomi and Kawamoto, Teruya and Fukase, Naomasa and Sawada, Ryoko and Fujiwara, Shuichi and Fujita, Ikuo and Fujimoto, Takuya and Morishita, Masayuki and Yahiro, Shunsuke and Miyamoto, Tomohiro and Saito, Masanori and Sugaya, Jun and Hayashi, Katsuhiro and Kawashima, Hiroyuki and Torigoe, Tomoaki and Nakamura, Tomoki and Kondo, Hiroya and Wakamatsu, Toru and Watanuki, Munenori and Kito, Munehisa and Tsukushi, Satoshi and Nagano, Akihito and Outani, Hidetatsu and Toki, Shunichi and Nishimura, Shunji and Kobayashi, Hiroshi and Watanabe, Itsuo and Demizu, Yusuke and Sasaki, Ryohei and Fukumoto, Takumi and Matsumoto, Tomoyuki and Kuroda, Ryosuke and Akisue, Toshihiro},
  title = {Comparison of clinical outcome between surgical treatment and particle beam therapy for pelvic bone sarcomas: A retrospective multicenter study in Japan},
  journal = {Journal of Orthopaedic Science},
  year = {2025},
  doi = {10.1016/j.jos.2024.06.007}
}
Kostenlos starten →